Search Results 91-100 of 16796 for Radioisotope

  1. Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia - Mayo Clinic

    Creatinine clearance or radioisotope glomerular filtration rate (GFR) ≥ 70 mL/min/1.73 m^2 or. A serum creatinine based on age/gender as follows: 1 to < 2 ...

  2. Combination Chemotherapy in Treating Younger Patients with Newly Diagnosed, Non-Metastatic Desmoplastic Medulloblastoma - Mayo Clinic

    Creatinine clearance or radioisotope glomerular filtration rate (GFR) ≥ 70 mL/min/1.73 m^2 or a serum creatinine based on age/gender as follows: 1 month to ...

  3. Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations - Mayo Clinic

    Participation eligibility · Creatinine clearance or radioisotope GFR >70 mL/min/1.73 m2 or - A serum creatinine based on age/gender as follows: Creatinine ...

  4. A Study to Determine the Tradeoffs between CT Image Quality and Patient Radiation Dose - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. A Study to Compare Nivolumab or Brentuximab Vedotin Plus Combination Chemotherapy to Treat Patients with Newly-diagnosed Stage III-IV Classic Hodgkin Lymphoma - Mayo Clinic

    Measured or calculated creatinine clearance or radioisotope glomerular filtration rate (GFR) ≥ 70 ml/min/1.73 m^2; or; Serum creatinine ≤ 1.5 x ...

  6. Alisertib in Treating Young Patients with Recurrent or Refractory Solid Tumors or Leukemia - Mayo Clinic

    Creatinine clearance or radioisotope glomerular filtration rate (GFR) 70 mL/min/1.73 m^2 or a serum creatinine based on age/gender as follows: 1 to < 2 ...

  7. A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT - Mayo Clinic

    - Hemoglobin ≥ 8.0 g/dL (may receive red blood cell [RBC] transfusions) (within 7 days prior to enrollment). - Creatinine clearance or radioisotope ...

  8. Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations - Mayo Clinic

    Creatinine clearance or radioisotope glomerular filtration rate (GFR) ≥ 70 mL/min/1.73 m^2 OR a serum creatinine based on age/gender as follows: 3 to < 6 ...

  9. Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

    Creatinine clearance or radioisotope glomerular filtration rate ≥ 70 mL/min OR serum creatinine normal based on age/gender as follows: ≤ 0.4 mg/dL (for ...

  10. A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation - Mayo Clinic

    ... radioisotopes; No evidence of pelvic floor dysfunction; If clinically indicated, absence of an evacuation disorder should be confirmed within 30 days prior to ...